Selected research
Market Structure
Global Acyl CoA Desaturase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Acyl CoA Desaturase market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Acyl CoA Desaturase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Acyl CoA Desaturase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Acyl CoA Desaturase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Acyl CoA Desaturase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Acyl CoA Desaturase include Sanofi, Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc, Xenon Pharmaceuticals Inc., Thesan Pharmaceuticals, Inc., Galmed Pharmaceuticals Ltd and Daiichi Sankyo Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Acyl CoA Desaturase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Acyl CoA Desaturase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Acyl CoA Desaturase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Acyl CoA Desaturase market size, projected growth trends, production technologies, key applications, and end-use industries.
Acyl CoA Desaturase Segment by Company
Sanofi
Johnson & Johnson
Novartis AG
GlaxoSmithKline Plc
Xenon Pharmaceuticals Inc.
Thesan Pharmaceuticals, Inc.
Galmed Pharmaceuticals Ltd
Daiichi Sankyo Co Ltd
Acyl CoA Desaturase Segment by Type
Aramchol
TSN-2898
T-3764518
Others
Acyl CoA Desaturase Segment by Application
Metastatic Renal Cell Carcinoma
Acne Vulgaris
Colorectal Cancer
Liver Fibrosis
Others
Acyl CoA Desaturase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acyl CoA Desaturase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acyl CoA Desaturase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acyl CoA Desaturase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Acyl CoA Desaturase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acyl CoA Desaturase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acyl CoA Desaturase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Acyl CoA Desaturase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Aramchol
- TSN-2898
- T-3764518
- Others
Applications
- Metastatic Renal Cell Carcinoma
- Acne Vulgaris
- Colorectal Cancer
- Liver Fibrosis
- Others
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis AG
- GlaxoSmithKline Plc
- Xenon Pharmaceuticals Inc.
- Thesan Pharmaceuticals, Inc.
- Galmed Pharmaceuticals Ltd
- Daiichi Sankyo Co Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Acyl CoA Desaturase Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Acyl CoA Desaturase Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Acyl CoA Desaturase Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Acyl CoA Desaturase Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Acyl CoA Desaturase Market Dynamics
- 2.1 Acyl CoA Desaturase Industry Trends
- 2.2 Acyl CoA Desaturase Industry Drivers
- 2.3 Acyl CoA Desaturase Industry Opportunities and Challenges
- 2.4 Acyl CoA Desaturase Industry Restraints
3 Acyl CoA Desaturase Market by Manufacturers
- 3.1 Global Acyl CoA Desaturase Revenue by Manufacturers (2021-2026)
- 3.2 Global Acyl CoA Desaturase Sales by Manufacturers (2021-2026)
- 3.3 Global Acyl CoA Desaturase Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Acyl CoA Desaturase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Acyl CoA Desaturase Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Acyl CoA Desaturase Manufacturers, Product Type & Application
- 3.7 Global Acyl CoA Desaturase Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Acyl CoA Desaturase Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Acyl CoA Desaturase Players Market Share by Revenue in 2025
- 3.8.3 2025 Acyl CoA Desaturase Tier 1, Tier 2, and Tier 3
4 Acyl CoA Desaturase Market by Type
- 4.1 Acyl CoA Desaturase Type Introduction
- 4.1.1 Aramchol
- 4.1.2 TSN-2898
- 4.1.3 T-3764518
- 4.1.4 Others
- 4.2 Global Acyl CoA Desaturase Sales by Type
- 4.2.1 Global Acyl CoA Desaturase Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Acyl CoA Desaturase Sales by Type (2021-2032)
- 4.2.3 Global Acyl CoA Desaturase Sales Market Share by Type (2021-2032)
- 4.3 Global Acyl CoA Desaturase Revenue by Type
- 4.3.1 Global Acyl CoA Desaturase Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Acyl CoA Desaturase Revenue by Type (2021-2032)
- 4.3.3 Global Acyl CoA Desaturase Revenue Market Share by Type (2021-2032)
5 Acyl CoA Desaturase Market by Application
- 5.1 Acyl CoA Desaturase Application Introduction
- 5.1.1 Metastatic Renal Cell Carcinoma
- 5.1.2 Acne Vulgaris
- 5.1.3 Colorectal Cancer
- 5.1.4 Liver Fibrosis
- 5.1.5 Others
- 5.2 Global Acyl CoA Desaturase Sales by Application
- 5.2.1 Global Acyl CoA Desaturase Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Acyl CoA Desaturase Sales by Application (2021-2032)
- 5.2.3 Global Acyl CoA Desaturase Sales Market Share by Application (2021-2032)
- 5.3 Global Acyl CoA Desaturase Revenue by Application
- 5.3.1 Global Acyl CoA Desaturase Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Acyl CoA Desaturase Revenue by Application (2021-2032)
- 5.3.3 Global Acyl CoA Desaturase Revenue Market Share by Application (2021-2032)
6 Global Acyl CoA Desaturase Sales by Region
- 6.1 Global Acyl CoA Desaturase Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Acyl CoA Desaturase Sales by Region (2021-2032)
- 6.2.1 Global Acyl CoA Desaturase Sales by Region (2021-2026)
- 6.2.2 Global Acyl CoA Desaturase Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Acyl CoA Desaturase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Acyl CoA Desaturase Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Acyl CoA Desaturase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Acyl CoA Desaturase Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Acyl CoA Desaturase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Acyl CoA Desaturase Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Acyl CoA Desaturase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Acyl CoA Desaturase Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Acyl CoA Desaturase Revenue by Region
- 7.1 Global Acyl CoA Desaturase Revenue by Region
- 7.1.1 Global Acyl CoA Desaturase Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Acyl CoA Desaturase Revenue by Region (2021-2026)
- 7.1.3 Global Acyl CoA Desaturase Revenue by Region (2027-2032)
- 7.1.4 Global Acyl CoA Desaturase Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Acyl CoA Desaturase Revenue (2021-2032)
- 7.2.2 North America Acyl CoA Desaturase Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Acyl CoA Desaturase Revenue (2021-2032)
- 7.3.2 Europe Acyl CoA Desaturase Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Acyl CoA Desaturase Revenue (2021-2032)
- 7.4.2 Asia-Pacific Acyl CoA Desaturase Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Acyl CoA Desaturase Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Acyl CoA Desaturase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Acyl CoA Desaturase Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Acyl CoA Desaturase Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Novartis AG
- 8.3.1 Novartis AG Company Information
- 8.3.2 Novartis AG Business Overview
- 8.3.3 Novartis AG Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis AG Acyl CoA Desaturase Product Portfolio
- 8.3.5 Novartis AG Recent Developments
- 8.4 GlaxoSmithKline Plc
- 8.4.1 GlaxoSmithKline Plc Company Information
- 8.4.2 GlaxoSmithKline Plc Business Overview
- 8.4.3 GlaxoSmithKline Plc Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GlaxoSmithKline Plc Acyl CoA Desaturase Product Portfolio
- 8.4.5 GlaxoSmithKline Plc Recent Developments
- 8.5 Xenon Pharmaceuticals Inc.
- 8.5.1 Xenon Pharmaceuticals Inc. Company Information
- 8.5.2 Xenon Pharmaceuticals Inc. Business Overview
- 8.5.3 Xenon Pharmaceuticals Inc. Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Xenon Pharmaceuticals Inc. Acyl CoA Desaturase Product Portfolio
- 8.5.5 Xenon Pharmaceuticals Inc. Recent Developments
- 8.6 Thesan Pharmaceuticals, Inc.
- 8.6.1 Thesan Pharmaceuticals, Inc. Company Information
- 8.6.2 Thesan Pharmaceuticals, Inc. Business Overview
- 8.6.3 Thesan Pharmaceuticals, Inc. Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Thesan Pharmaceuticals, Inc. Acyl CoA Desaturase Product Portfolio
- 8.6.5 Thesan Pharmaceuticals, Inc. Recent Developments
- 8.7 Galmed Pharmaceuticals Ltd
- 8.7.1 Galmed Pharmaceuticals Ltd Company Information
- 8.7.2 Galmed Pharmaceuticals Ltd Business Overview
- 8.7.3 Galmed Pharmaceuticals Ltd Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Galmed Pharmaceuticals Ltd Acyl CoA Desaturase Product Portfolio
- 8.7.5 Galmed Pharmaceuticals Ltd Recent Developments
- 8.8 Daiichi Sankyo Co Ltd
- 8.8.1 Daiichi Sankyo Co Ltd Company Information
- 8.8.2 Daiichi Sankyo Co Ltd Business Overview
- 8.8.3 Daiichi Sankyo Co Ltd Acyl CoA Desaturase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Daiichi Sankyo Co Ltd Acyl CoA Desaturase Product Portfolio
- 8.8.5 Daiichi Sankyo Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Acyl CoA Desaturase Value Chain Analysis
- 9.1.1 Acyl CoA Desaturase Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Acyl CoA Desaturase Production Mode & Process
- 9.2 Acyl CoA Desaturase Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Acyl CoA Desaturase Distributors
- 9.2.3 Acyl CoA Desaturase Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst